Russell Investments Group, Ltd. Collegium Pharmaceutical, Inc Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 19,872 shares of COLL stock, worth $578,473. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,872
Previous 13,596 46.16%
Holding current value
$578,473
Previous $437,000 75.51%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$31.4 - $39.07 $197,066 - $245,203
6,276 Added 46.16%
19,872 $767,000
Q2 2024

Aug 08, 2024
SELL
$31.36 - $39.99 $611,143 - $779,325
-19,488 Reduced 58.9%
13,596 $437,000
Q1 2024

May 08, 2024
BUY
$31.23 - $40.91 $31,573 - $41,360
1,011 Added 3.15%
33,084 $1.28 Million
Q4 2023

Feb 05, 2024
BUY
$21.16 - $30.8 $143,803 - $209,316
6,796 Added 26.89%
32,073 $987,000
Q3 2023

Nov 13, 2023
BUY
$21.23 - $24.28 $144,024 - $164,715
6,784 Added 36.68%
25,277 $564,000
Q2 2023

Aug 10, 2023
SELL
$21.06 - $24.0 $1.84 Million - $2.1 Million
-87,503 Reduced 82.55%
18,493 $397,000
Q1 2023

May 09, 2023
BUY
$23.0 - $29.88 $1.83 Million - $2.38 Million
79,622 Added 301.9%
105,996 $2.54 Million
Q4 2022

Feb 08, 2023
BUY
$16.14 - $23.55 $273,831 - $399,549
16,966 Added 180.34%
26,374 $611,000
Q3 2022

Nov 04, 2022
SELL
$15.46 - $20.1 $1.38 Million - $1.79 Million
-88,968 Reduced 90.44%
9,408 $150,000
Q2 2022

Jul 29, 2022
SELL
$14.22 - $20.88 $148,271 - $217,715
-10,427 Reduced 9.58%
98,376 $1.74 Million
Q1 2022

May 05, 2022
BUY
$17.2 - $22.5 $1.87 Million - $2.45 Million
108,803 New
108,803 $2.21 Million
Q2 2020

Aug 05, 2020
SELL
$15.49 - $23.51 $1.24 Million - $1.88 Million
-80,178 Closed
0 $0
Q1 2020

May 06, 2020
BUY
$13.89 - $25.45 $1.11 Million - $2.04 Million
80,178 New
80,178 $1.32 Million
Q2 2019

Aug 09, 2019
SELL
$10.62 - $16.59 $45,166 - $70,557
-4,253 Closed
0 $0
Q1 2019

May 13, 2019
BUY
$13.58 - $18.72 $57,755 - $79,616
4,253 New
4,253 $67,000
Q3 2018

Oct 26, 2018
SELL
$14.16 - $24.3 $2.21 Million - $3.79 Million
-155,929 Closed
0 $0
Q2 2018

Aug 08, 2018
SELL
$21.79 - $28.29 $86,811 - $112,707
-3,984 Reduced 2.49%
155,929 $3.72 Million
Q1 2018

May 11, 2018
BUY
$18.15 - $29.21 $2.9 Million - $4.67 Million
159,913 New
159,913 $4.09 Million

Others Institutions Holding COLL

# of Institutions
255
Shares Held
36.9M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $993M
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email